For patients with stage T1a renal cell carcinoma (RCC), the use of thermal ablation has been increasing, while the use of radical nephrectomy has been declining.

Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the ...

Advancements in ablation technologies, expanding healthcare access in emerging economies, and strategic investments by global ...

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

Medtronic plc is rated a Buy with solid growth prospects, balance sheet remains A-rated and shares are undervalued. Learn ...

Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...

Johns Hopkins biomedical engineers Ishan Vatsaraj, Stanley Chun Ming Wu, and Jaemyung Shin have been awarded highly ...

Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...

It could be another tough year for the once-soaring drugmaker.

Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer and continues to be a major cause of cancer ...

Up to 189 health conditions could potentially affect your ability to drive, with seven specific conditions that must be ...

As Trump considers buying Greenland, the island grapples with hazardous US military waste and environmental liabilities.